Premium
Imbalance of peroxisome proliferator‐activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis
Author(s) -
Fukunaga Hideo,
Kishiro Masahiko,
Akimoto Katsumi,
Ohtsuka Yoshikazu,
Nagata Satoru,
Shimizu Toshiaki
Publication year - 2010
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/j.1442-200x.2010.03160.x
Subject(s) - adiponectin , medicine , endocrinology , peroxisome proliferator activated receptor , receptor , apolipoprotein b , chemokine , apolipoprotein e , disease , cholesterol , obesity , insulin resistance
Background: It remains controversial whether Kawasaki disease (KD) is a risk factor for the onset of atherosclerosis. An imbalance of peroxisome proliferator‐activated receptor γ (PPARγ) and adiponectin appears to play a role in the onset of atherosclerosis in adults, and we therefore examined PPARγ mRNA expression and adiponectin profiles in the peripheral white blood cells obtained from KD patients. Methods: A total of 50 subjects were studied: nine patients with acute KD, 20 patients with convalescent KD, and 21 age‐matched controls. The gene expression of PPARγ, monocyte chemoattractant protein‐1, and CC chemokine receptor 2 present in the blood were quantified. The relative gene expression, adiponectin levels, and the three adiponectin isoforms were compared among the subjects. Results: The abundance of PPARγ and CC chemokine receptor 2 mRNA was significantly increased in convalescent KD patients. The monocyte chemoattractant protein‐1 level was also increased in convalescent KD patients. The level of high‐molecular‐weight adiponectin was significantly lower in convalescent patients compared to controls. The PPARγ transcription levels negatively correlated with apolipoprotein A‐I levels in acute KD patients. Conclusions: The transcript abundance of PPARγ and low levels of high‐molecular‐weight adiponectin in KD patients may have important clinical implications on the development of premature atherosclerosis. Because the potential risk for developing atherosclerosis has not yet been verified, long‐term observation is important, even in convalescent KD patients without coronary artery lesions.